Showing results (21-30 of 90) with videos related to
Sort By:
Pageof 9
EJNMMI Radiopharmacy and Chemistry|March 6, 2018
Pretargeting for imaging and therapy in oncological nuclear medicineClément Bailly, Caroline Bodet-Milin, Caroline Rousseau, et al.European Journal of Nuclear Medicine and Molecular Imaging|May 10, 2008
ARRONAX, a high-energy and high-intensity cyclotron for nuclear medicineFerid Haddad, Ludovic Ferrer, Arnaud Guertin, et al.Frontiers in Oncology|June 27, 2013
Improvement of radioimmunotherapy using pretargetingEric Frampas, Caroline Rousseau, Caroline Bodet-Milin, et al.Cancer|February 4, 2010
Pretargeted radioimmunotherapy in rapidly progressing, metastatic, medullary thyroid cancerFrançoise Kraeber-Bodéré, Pierre-Yves Salaun, Aurore Oudoux, et al.European Journal of Nuclear Medicine and Molecular Imaging|May 25, 2007
Prospective comparison of two gamma probes for intraoperative detection of 18F-FDG: in vitro assessment and clinical evaluation in differentiated thyroid cancer patients with iodine-negative recurrenceChantal Curtet, Thomas Carlier, Eric Mirallié, et al.Journal of Chromatography. A|September 19, 2018
Coupling a gamma-ray detector with asymmetrical flow field flow fractionation (AF4): Application to a drug-delivery system for alpha-therapySandrine Huclier-Markai, Alicia Grivaud-Le Du, Estelle N'tsiba, et al.Cancer Research|February 20, 2007
Sphingosine-1-phosphate protects proliferating endothelial cells from ceramide-induced apoptosis but not from DNA damage-induced mitotic deathStéphanie Bonnaud, Colin Niaudet, Géraldine Pottier, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Mechanisms of cell sensitization to alpha radioimmunotherapy by doxorubicin or paclitaxel in multiple myeloma cell linesStephane Supiot, Sebastien Gouard, Josiane Charrier, et al.Scientific Reports|November 18, 2016
The archaeal "7 kDa DNA-binding" proteins: extended characterization of an old gifted familyValentina Kalichuk, Ghislaine Béhar, Axelle Renodon-Cornière, et al.Scientific Reports|June 2, 2017
Targeted radionuclide therapy with astatine-211: Oxidative dehalogenation of astatobenzoate conjugatesDavid Teze, Dumitru-Claudiu Sergentu, Valentina Kalichuk, et al.Pageof 9